<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00229099</url>
  </required_header>
  <id_info>
    <org_study_id>CT05-02</org_study_id>
    <nct_id>NCT00229099</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety Study of GerEPO</brief_title>
  <official_title>A Randomized, Multi-Center, Open Label Trial to Establish the Therapeutic Equivalence Between GerEpo and Eprex® and to Determine the Long Term Safety Profile of GerEpo in Patients on Hemodialysis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ministry of Health, Malaysia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ministry of Health, Malaysia</source>
  <brief_summary>
    <textblock>
      The purpose of the study is to establish the equivalence of GerEpo with the standard
      treatment Eprex® for a treatment period of 12 weeks in patients on Hemodialysis with respect
      to hemoglobin response and to establish the longer-term safety profile of GerEpo, with
      special regards for the occurrence of Pure Red Cell Aplasia (PRCA) and other immunogenicity
      related adverse event
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      270 patients on Hemodialysis from 25 participating sites who meet inclusion/exclusion
      criteria will be enrolled into the trial. At the end of the comparative trial, subjects on
      either arm of the study may opt to enter a longer term cohort study designed to establish the
      longer-term safety profile of GerEpo, with special regards for the occurrence of Pure Red
      Cell Aplasia (PRCA) and other immunogenicity related adverse event.

      This second part of the study is also opened to all subjects who have given written informed
      consent, and have ESRF with CRF related anemia who according to current guideline should be
      treated with Epoetin. Subjects need not be included in the first part of the study.

      All patients shall be treated with GerEpo and thereafter observed for at least 1 year to
      actively monitor for the occurrence of PRCA and other immunogenicity related adverse events.
      The cohort study shall continue until at least 10,000 patient-years of observation have
      accrued on the study database.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2005</start_date>
  <completion_date>November 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To establish the therapeutic equivalence of GerEpo with the standard treatment Eprex® for a treatment period of 12 weeks in patients on Hemodialysis with respect to hemoglobin response.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>• To compare GerEpo with Eprex® with respect to their respective frequency of adverse events</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To monitor the occurrence of PRCA and other immunogenicity related adverse events among patients on GerEpo observed for at least a year on therapy.</measure>
  </secondary_outcome>
  <enrollment>270</enrollment>
  <condition>Chronic Renal Failure Related Anemia</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>GerEPO</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Written informed consent obtained.

          2. Patients age between 18 and 70 years.

          3. Patients who are medically stable on hemodialysis for a minimum of 3 months.

          4. Patients on Eprex® treatment for CRF related anemia and maintaining Hb level at or
             above 9 g/dL(90g/L) while on a stable dose (no change in dose) of Epoetin within 6
             weeks preceding the screening phase of this study.

          5. Patients who have a serum ferritin level greater than 100μg/L and/or transferrin
             saturation at least 20% within 3 months preceding the screening phase of this study.

        Exclusion Criteria:

          1. Pregnant or nursing woman, or women of childbearing potential without an effective
             method of birth control. Effective birth control methods are oral contraception,
             Norplant, surgical sterilization, IUD or diaphragms in conjunction with spermicidal
             foam and condom on the male partner.

          2. Participation in any drug trial in which the patient received an Epoetin
             investigational drug within 30 days preceding the screening phase of this study.

          3. Those persons directly involved in the conduct of the study.

          4. Poorly controlled hypertension with diastolic blood pressures persistently greater
             than 110 mmHg at baseline observation.

          5. History of seizure disorder.

          6. Active acute or chronic infection or inflammatory disease.

          7. Any illness that had required hospitalization within the last one month.

          8. Had blood transfusion within the last three months.

          9. Significant hematologic abnormalities (Evidence of hemolysis by laboratory tests,
             unexplained acquired microcytosis, thrombocytosis (&gt;500,000/mm3))

         10. Severe hyperparathyroidism

         11. Diagnosed to have malignant tumor or who have residual tumor after anti-cancer
             therapy.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Zaki Morad, MRCP, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>Netherlands: Ministry of Health, Welfare and Sports</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Sultanah Aminah</name>
      <address>
        <city>Johor Bharu</city>
        <state>Johor</state>
        <zip>80100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pontian Rotary Haemodialysis Centre</name>
      <address>
        <city>Pontian</city>
        <state>Johor</state>
        <zip>82000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Alor Setar</name>
      <address>
        <city>Alor Setar</city>
        <state>Kedah</state>
        <zip>05100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Kota Bharu</name>
      <address>
        <city>Kota Bharu</city>
        <state>Kelantan</state>
        <zip>15590</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusat Hemodialisis Mawar (Seremban)</name>
      <address>
        <city>Seremban</city>
        <state>Negeri Sembilan</state>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Seremban General Hospital</name>
      <address>
        <city>Seremban</city>
        <state>Negeri Sembilan</state>
        <zip>70300</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Tengku Ampuan Afzan</name>
      <address>
        <city>Kuantan</city>
        <state>Pahang</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pahang Buddhist Association</name>
      <address>
        <city>Kuantan</city>
        <state>Pahang</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Ipoh</name>
      <address>
        <city>Ipoh</city>
        <state>Perak</state>
        <zip>30990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Taiping</name>
      <address>
        <city>Taiping</city>
        <state>Perak</state>
        <zip>34000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Kangar</name>
      <address>
        <city>Kangar</city>
        <state>Perlis</state>
        <zip>01000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Asia Renal Care,Bukit Mertajam</name>
      <address>
        <city>Bukit Mertajam</city>
        <state>Pulau Pinang</state>
        <zip>14000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Persatuan Buah Pinggang Sabah</name>
      <address>
        <city>Kota Kinabalu</city>
        <state>Sabah</state>
        <zip>88100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Queen Elizabeth</name>
      <address>
        <city>Kota Kinabalu</city>
        <state>Sabah</state>
        <zip>88586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Timberland Medical Centre</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <zip>93250</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>MAA Medicare Kidney Charity Dialysis Centre</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <zip>93540</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Umum Sarawak</name>
      <address>
        <city>Kuching</city>
        <state>Sarawak</state>
        <zip>93586</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ampang Putri Specialist Hospital</name>
      <address>
        <city>Ampang</city>
        <state>Selangor</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Selayang</name>
      <address>
        <city>Batu Caves</city>
        <state>Selangor</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Tengku Ampuan Rahimah</name>
      <address>
        <city>Klang</city>
        <state>Selangor</state>
        <zip>41200</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP Menon Dialysis Centre</name>
      <address>
        <city>Klang</city>
        <state>Selangor</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Haemodialysis Unit , Sunway Medical Centre</name>
      <address>
        <city>Petaling Jaya</city>
        <state>Selangor</state>
        <zip>46150</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP Menon Dialysis Centre, Megah Medical Specialist Centre</name>
      <address>
        <city>PJ</city>
        <state>Selangor</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Terengganu</name>
      <address>
        <city>Kuala Terengganu</city>
        <state>Terengganu</state>
        <zip>20400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>SP Menon Dialysis Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <zip>50400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pusat Hemodialisis, Yayasan Felda</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <zip>54000</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>The Kidney Dialysis Centre</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <zip>58100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pantai Medical Centre, Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <zip>59100</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Kuala Lumpur</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Tung Shin Hospital</name>
      <address>
        <city>Kuala Lumpur</city>
        <state>Wilayah Persekutuan</state>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Melaka</name>
      <address>
        <city>Melaka</city>
        <zip>75400</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Penang General Hospital</name>
      <address>
        <city>Pulau Pinang</city>
        <zip>10990</zip>
        <country>Malaysia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Malaysia</country>
  </location_countries>
  <link>
    <url>http://www.crc.gov.my</url>
    <description>the link is an academic research organisation for the trial</description>
  </link>
  <verification_date>December 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 28, 2005</study_first_submitted>
  <study_first_submitted_qc>September 28, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 29, 2005</study_first_posted>
  <last_update_submitted>October 25, 2006</last_update_submitted>
  <last_update_submitted_qc>October 25, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2006</last_update_posted>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

